xylazine has been researched along with Cranial Nerve II Injuries in 1 studies
Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kurimoto, T | 1 |
Ishii, M | 1 |
Tagami, Y | 1 |
Nishimura, M | 1 |
Miyoshi, T | 1 |
Tsukamoto, Y | 1 |
Mimura, O | 1 |
1 other study available for xylazine and Cranial Nerve II Injuries
Article | Year |
---|---|
Xylazine promotes axonal regeneration in the crushed optic nerve of adult rats.
Topics: Adrenergic alpha-Agonists; Animals; Axons; Cholera Toxin; Drug Administration Schedule; GAP-43 Prote | 2006 |